Does Insurance Cover GLP-1 for Fatty Liver?

The RX Index is a pricing intelligence and comparison resource for GLP-1 telehealth providers.

Find your row — then read the section that matches

Does insurance cover GLP-1 for fatty liver?

Insurance can cover a GLP-1 for fatty liver, but usually only when the request matches an FDA-approved use — most often Wegovy injection for adults with noncirrhotic MASH and moderate-to-advanced fibrosis (stages F2 to F3). Plain "fatty liver" or MASLD without that MASH diagnosis is a much weaker request, because many plans treat it as off-label. The single biggest factor is what your medical chart actually says.

The words that decide coverage

Doctors recently renamed these conditions, so you'll see old and new terms floating around:

Here's the table that decides your coverage:

Why the answer changed in 2025

For years, fatty liver gave you no FDA-approved GLP-1 to point to, so coverage came down to luck. That flipped in August 2025, when the FDA gave Wegovy injection an accelerated approval to treat adults with noncirrhotic MASH and moderate-to-advanced liver scarring. It became the first GLP-1 ever approved for a liver disease — and that approval is the reason a real coverage path now exists.

Coverage doesn't mean automatic. It doesn't mean free. It doesn't mean every GLP-1, and it doesn't mean no paperwork. It means your plan has a path — if the drug, the diagnosis, the documents, and the plan rules all line up.

Which GLP-1 is covered for fatty liver: Wegovy, Ozempic, Zepbound, or Mounjaro?

Wegovy injection is the only GLP-1 with an FDA-approved fatty-liver use, for noncirrhotic MASH with F2 to F3 fibrosis. Ozempic, Mounjaro, and Zepbound are not approved for the liver, so plans usually won't cover them for fatty liver unless you also have a separate condition they are approved for — most commonly type 2 diabetes.

Here's the trap: Ozempic and Wegovy are the same active ingredient (semaglutide). Naturally, you'd think "if Wegovy is approved for my liver, my plan should cover Ozempic for it too." Plans don't see it that way. They cover the brand-plus-use pair. Wegovy is the brand approved for MASH. Ozempic isn't. So for a liver request, Wegovy is the name that belongs on the paperwork.

What does insurance actually require to cover Wegovy for MASH?

Across real insurer policies, the pattern is never "fatty liver equals covered." It's a checklist: an adult patient, a MASH diagnosis, F2–F3 fibrosis confirmed by a recent test, no cirrhosis, a liver or hormone specialist involved, diet and exercise, and the right drug formulation. Miss one piece and you get denied — even with a valid prescription.

We pulled an actual coverage policy and read it line by line. Here's what Cigna's Drug Coverage Policy IP0781 — its Metabolic Dysfunction-Associated Steatohepatitis – Wegovy Benefit Exclusion Overrides Policy for Individual and Family Plans, effective May 1, 2026 — requires to approve Wegovy injection for the liver:

How real payers handle it

Same drug, same diagnosis — and the rules are all over the map. This is exactly why no one can give you a clean yes or no until you check your plan.

Last verified: June 9, 2026. Notice that California's Medi-Cal needs no prior authorization for MASH (just the right diagnosis code), while Mississippi requires a full prior auth with a liver specialist. Your plan is its own world — check it directly.

How do I check whether my plan covers a GLP-1 for fatty liver?

Use the exact words your insurer recognizes — "Wegovy injection for noncirrhotic MASH with F2 to F3 fibrosis" — not "Ozempic for fatty liver" or "the weight-loss shot." Then confirm four things: is it on your formulary, does it need prior authorization, which diagnosis code they want, and what fibrosis proof they accept. The phrasing genuinely changes the answer.

Your 7-step coverage check

What if my insurance denied a GLP-1 for fatty liver?

Many fatty-liver denials come down to fixable paperwork — the request was processed as weight loss, the diagnosis was too vague, the fibrosis proof was missing, or the wrong formulation was requested. A denial is harder to beat when your chart doesn't support noncirrhotic MASH with F2 to F3 fibrosis, or your plan has no exception path. Read the denial letter first; it tells you exactly which gap to fix.

Does Medicare cover a GLP-1 for fatty liver or MASH?

For Medicare, MASH is a Part D question — not a Medicare GLP-1 Bridge question. CMS confirms that noncirrhotic MASH is eligible for Part D coverage, and that people with a MASH diagnosis should get their GLP-1 through their Part D plan, not the Bridge. The Bridge is a separate program for weight loss only.

Does Medicaid cover a GLP-1 for fatty liver?

Medicaid coverage for a GLP-1 for fatty liver depends entirely on your state — there's no single national yes or no. Some state Medicaid programs cover Wegovy for noncirrhotic MASH with almost no friction; others require a full prior authorization with a liver specialist and recent fibrosis testing.

Same drug, same diagnosis, two completely different rulebooks. Don't assume one state's rule is yours. Do this instead:

What does a GLP-1 for fatty liver cost without insurance?

If your plan says no, you have three realistic moves: appeal with the right documents, switch to a covered alternative (often a diabetes GLP-1 if you qualify), or pay cash. Cash-pay Wegovy through manufacturer-priced telehealth runs roughly $199 to $399 a month for the injection — versus around $1,350 a month at full retail. Don't give up on coverage until you've tried the MASH path and an exception.

Sources: NovoCare and Ro pricing pages. Last verified: June 9, 2026. Prices and promotions change fast — re-check before you commit.

For a full comparison: GLP-1 cost without insurance: FDA-approved cash-pay options and best GLP-1 providers that help with prior authorization.

What if I only have fatty liver or MASLD, not MASH with F2–F3 fibrosis?

If your chart says "fatty liver" or MASLD without MASH or documented scarring, a GLP-1 is hard to get covered for the liver alone, because no GLP-1 is FDA-approved for that stage yet. Your next step isn't to force a claim — it's to ask whether you need fibrosis testing, or whether you qualify through another condition like type 2 diabetes or obesity.

Honestly, the hardest part is figuring out which of these is you. That's exactly what our matching quiz is for — it asks a few questions and gives you a personalized action plan, including the realistic coverage path for your situation. Find my GLP-1 path →

Is there a non-GLP-1 drug for fatty liver?

Yes — Rezdiffra (resmetirom) is FDA-approved for adults with noncirrhotic MASH and moderate-to-advanced fibrosis. It's not a GLP-1; it's a different kind of liver-targeted drug. If you have MASH, it's worth asking your GI or liver doctor whether the right coverage question for you is Wegovy, Rezdiffra, or something else.

Rezdiffra was the first drug approved specifically for MASH with fibrosis (back in March 2024), and it works through a completely different pathway than GLP-1s. We won't tell you which one to pick — that's a medical decision for you and your specialist, based on your liver, your other conditions, and what your plan covers. Just know the option exists, so a GLP-1 denial doesn't feel like the end of the road.

Where should I start if I want insurance-friendly help online?

For this specific question — getting an FDA-approved GLP-1 covered for fatty liver — Ro is the best-fit option for people with commercial or FEHB insurance, because it offers a free coverage check and an insurance concierge that handles prior authorization. It's the wrong choice if you're on Medicare or Medicaid, if your denial needs liver-specialist documentation, or if you have advanced liver disease.

What should I ask my doctor and my insurer?

The best question isn't "Can I get a GLP-1 for fatty liver?" It's "Do my records support noncirrhotic MASH with F2–F3 fibrosis, and does my plan cover Wegovy injection for that?"

Frequently asked questions

Does insurance cover GLP-1 for fatty liver?

Sometimes. The strongest path is Wegovy injection for documented noncirrhotic MASH with moderate-to-advanced fibrosis (stages F2 to F3). Plain "fatty liver" or MASLD without that MASH diagnosis is usually a much weaker request, and most plans require prior authorization plus proof of your fibrosis stage.

Is Wegovy covered by insurance for MASH?

Often, when the prior-authorization criteria are met. Wegovy injection is FDA-approved for noncirrhotic MASH with F2 to F3 fibrosis, and a MASH-based request can be covered even on plans that exclude weight-loss drugs -- but it requires documentation of the diagnosis, the fibrosis stage, and noncirrhotic status.

Is Ozempic covered for fatty liver?

Usually not for fatty liver by itself, because Ozempic is FDA-approved for type 2 diabetes (and related heart and kidney uses in people with diabetes), not the liver -- so a liver prescription is off-label. It may be covered if you also have type 2 diabetes, which is an approved use.

Is Zepbound or Mounjaro covered for fatty liver?

Usually not as a fatty-liver treatment. Zepbound is approved for obesity and sleep apnea, and Mounjaro for type 2 diabetes -- neither is FDA-approved for MASH, so coverage for the liver alone is hard despite promising trial data.

Does insurance cover the Wegovy pill for fatty liver?

No. The Wegovy pill is not the MASH-approved formulation; the FDA-approved MASH use is for Wegovy injection. If your request is about fatty liver or MASH coverage, make sure the paperwork says Wegovy injection.

What fibrosis stage qualifies for Wegovy coverage for MASH?

Moderate-to-advanced fibrosis -- stages F2 to F3 -- without cirrhosis (F4). Both the FDA approval and insurer policies repeatedly use the F2 to F3, noncirrhotic threshold, confirmed by a biopsy, FibroScan, MRE, or ELF test.

Does Medicare cover Wegovy for MASH?

Yes, this is a Part D question. CMS confirms noncirrhotic MASH is eligible for Part D coverage, so beneficiaries with a MASH diagnosis get their GLP-1 through their Part D plan -- not through the Medicare GLP-1 Bridge, which is for weight management only.

Does Medicaid cover a GLP-1 for fatty liver?

It depends on your state. California's Medi-Cal covers Wegovy for noncirrhotic MASH with no prior authorization (just the right diagnosis code), while Mississippi Medicaid requires a full prior authorization with a liver specialist -- so check your own state's Medicaid drug policy.

What if my plan excludes weight-loss drugs?

Ask whether the exclusion still applies when Wegovy injection is prescribed for noncirrhotic MASH rather than weight loss. Some insurer policies are written specifically to override a weight-loss exclusion for the MASH use.

What diagnosis code should be used?

There's no single universal code, so ask your plan which one it requires for the MASH use. The condition is commonly coded as K75.81 (MASH/NASH), but some plans use other codes -- for example, California's Medi-Cal requires K76.0 and/or K75.8 -- and a missing or wrong code is a frequent reason claims get rejected.

Does insurance cover compounded semaglutide for fatty liver?

No. Compounded GLP-1s are not FDA-approved and are not an insurance-covered path. If insurance coverage is your goal, you need an FDA-approved brand.

Is Rezdiffra a GLP-1?

No. Rezdiffra (resmetirom) is a different type of drug, but it's FDA-approved for adults with noncirrhotic MASH and moderate-to-advanced fibrosis -- so it's worth discussing with your liver specialist as an alternative to a GLP-1.

Can telehealth prescribe Wegovy for MASH?

A telehealth provider may help you access FDA-approved GLP-1s and navigate insurance, but MASH coverage usually hinges on liver-specific documentation -- like a fibrosis test and a specialist's involvement -- which often starts with your own doctor or a hepatologist.